Trastuzumab Supplier-Buyer Network — Trade Flow Analysis

Name: Trastuzumab Supplier-Buyer Trade Network Dataset — 179+ Indian Exporters, 22+ Importers, 108+ Countries (DGFT 2022–2026)
Creator: TransData Nexus
License: https://transdatanexus.com/terms
Keywords: Trastuzumab supplier network, Trastuzumab buyers, pharmaceutical export India, Trastuzumab trade data

TransData Nexus

Trastuzumab

India Pharmaceutical Trade Intelligence

$77.2M179 Suppliers108 CountriesHS 30049099

ExportsIndia → NETHERLANDS37.9%India → TURKEY13.1%

ImportsGERMANY → India$24.8B SWITZERLAND → India$448.1M

#1 Supplier: MYLAN LABORATORIES #1 Buyer: MYLAN IRELAND

Who Supplies Trastuzumab? Top Manufacturers & Buyers 2026 — MYLAN LABORATORIES LIMITED Leads | TransData Nexus | TransData Nexus

1MYLAN LABORATORIES LIMITED

MYLAN LABORATORIES LIMITED is the first-largest Trastuzumab exporter from India, with a market share of 51.7% and a total export value of $39.9M across 503 shipments. Their average shipment value of $79.4K is above the market average of $41.0K, suggesting premium or bulk contract pricing.

MYLAN LABORATORIES LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:

• MYLAN IRELAND LIMITED — $12.6M across 159 shipments (31.6% of this supplier's total exports)

• BIOSIMILAR COLLABORATIONS IRELAND L — $8.8M across 111 shipments (22.0% of this supplier's total exports)

• ABDI IBRAHIM ILAC SANAYI VE TICARET SANAYIMAH TUNC — $8.2M across 103 shipments (20.4% of this supplier's total exports)

• MYLAN IRELAND LTD — $6.3M across 80 shipments (15.9% of this supplier's total exports)

• PII OST-WEST EXPRESS — $4.0M across 51 shipments (10.1% of this supplier's total exports)

Key Insight: MYLAN LABORATORIES LIMITED's per-shipment value of $79.4K is 93% above the market average of $41.0K, consistent with large-order contracts or value-added formulations.

2BIOCON BIOLOGICS INDIA LIMITED

BIOCON BIOLOGICS INDIA LIMITED is the second-largest Trastuzumab exporter from India, with a market share of 11.8% and a total export value of $9.1M across 39 shipments. Their average shipment value of $233.8K is above the market average of $41.0K, suggesting premium or bulk contract pricing.

BIOCON BIOLOGICS INDIA LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:

• BIOCON BIOLOGICS UK LIMITED — $4.0M across 17 shipments (44.3% of this supplier's total exports)

• XXOSIXXLARXXNEWXX LIXXTED — $3.1M across 13 shipments (34.3% of this supplier's total exports)

• RV HEALTH CARE PTE LTD — $945.1K across 4 shipments (10.4% of this supplier's total exports)

• XXOCOXXBIOXXGICXXUK — $506.1K across 2 shipments (5.5% of this supplier's total exports)

• GETZ PHARMA PVT LTD — $500.7K across 2 shipments (5.5% of this supplier's total exports)

Key Insight: BIOCON BIOLOGICS INDIA LIMITED's per-shipment value of $233.8K is 470% above the market average of $41.0K, consistent with large-order contracts or value-added formulations.

3ZYDUS LIFESCIENCES LIMITED

ZYDUS LIFESCIENCES LIMITED is the third-largest Trastuzumab exporter from India, with a market share of 4.5% and a total export value of $3.4M across 68 shipments. Their average shipment value of $50.6K is above the market average of $41.0K, suggesting premium or bulk contract pricing.

ZYDUS LIFESCIENCES LIMITED serves 5 named buyers in our database. ZYDUS PHARMACEUTICALS M?XICO S.A. D is the dominant customer, accounting for 79.1% of this supplier's tracked business. Top customers include:

• ZYDUS PHARMACEUTICALS M?XICO S.A. D — $2.7M across 54 shipments (79.1% of this supplier's total exports)

• KIMIA FARMA TBK, PT — $261.4K across 5 shipments (7.6% of this supplier's total exports)

• KIMIA FARMA TBK, PT — $185.4K across 4 shipments (5.4% of this supplier's total exports)

• MEGA LIFESCIENCES PT — $140.8K across 3 shipments (4.1% of this supplier's total exports)

• RIPPLE PHARMACEUTICA — $130.7K across 3 shipments (3.8% of this supplier's total exports)

Key Insight: ZYDUS LIFESCIENCES LIMITED's per-shipment value of $50.6K is 23% above the market average of $41.0K, consistent with large-order contracts or value-added formulations.

4RELIANCE LIFE SCIENCES PRIVATE LIMITED

RELIANCE LIFE SCIENCES PRIVATE LIMITED is the fourth-largest Trastuzumab exporter from India, with a market share of 4.2% and a total export value of $3.2M across 75 shipments. Their average shipment value of $43.2K is above the market average of $41.0K, suggesting premium or bulk contract pricing.

RELIANCE LIFE SCIENCES PRIVATE LIMITED serves 5 named buyers in our database. GENERAL FOREIGN TRADE ORGANIZATION is the dominant customer, accounting for 75.9% of this supplier's tracked business. Top customers include:

• GENERAL FOREIGN TRADE ORGANIZATION — $2.5M across 57 shipments (75.9% of this supplier's total exports)

• SEAN DOMINICAN SRL — $336.1K across 8 shipments (10.4% of this supplier's total exports)

• LEVANT PULSE — $250.2K across 6 shipments (7.7% of this supplier's total exports)

• OCTELLE CO., LTD — $105.2K across 2 shipments (3.3% of this supplier's total exports)

• PHARMACHEM PRIVATE L — $87.7K across 2 shipments (2.7% of this supplier's total exports)

Key Insight: RELIANCE LIFE SCIENCES PRIVATE LIMITED's per-shipment value of $43.2K is 5% above the market average of $41.0K, consistent with large-order contracts or value-added formulations.

5BIOCON BIOLOGICS LIMITED

BIOCON BIOLOGICS LIMITED is the fifth-largest Trastuzumab exporter from India, with a market share of 1.6% and a total export value of $1.2M across 6 shipments. Their average shipment value of $201.9K is above the market average of $41.0K, suggesting premium or bulk contract pricing.

BIOCON BIOLOGICS LIMITED serves 1 named buyer in our database. MEDMART PHARMA (PVT) LTD is the dominant customer, accounting for 100.0% of this supplier's tracked business. Top customers include:

• MEDMART PHARMA (PVT) LTD — $1.2M across 6 shipments (100.0% of this supplier's total exports)

Key Insight: BIOCON BIOLOGICS LIMITED's per-shipment value of $201.9K is 392% above the market average of $41.0K, consistent with large-order contracts or value-added formulations.

6MEDWISE OVERSEAS PRIVATE LIMITED

MEDWISE OVERSEAS PRIVATE LIMITED is the fifth-largest Trastuzumab exporter from India, with a market share of 1.5% and a total export value of $1.1M across 4 shipments. Their average shipment value of $281.8K is above the market average of $41.0K, suggesting premium or bulk contract pricing.

MEDWISE OVERSEAS PRIVATE LIMITED serves 3 named buyers in our database. TO MEDICAMENTOS CONS is the dominant customer, accounting for 55.5% of this supplier's tracked business. Top customers include:

• TO MEDICAMENTOS CONS — $625.7K across 2 shipments (55.5% of this supplier's total exports)

• TO. — $409.1K across 1 shipments (36.3% of this supplier's total exports)

• TO. — $92.4K across 0 shipments (8.2% of this supplier's total exports)

Key Insight: MEDWISE OVERSEAS PRIVATE LIMITED's per-shipment value of $281.8K is 587% above the market average of $41.0K, consistent with large-order contracts or value-added formulations.

1Netherlands

Netherlands ranks as the first-largest destination for Trastuzumab imports from India, with a total trade value of $29.3M across 219 shipments — representing a 37.9% share of all Trastuzumab exports. The average shipment value of $133.6K is above the global average of $41.0K, indicating high-value procurement contracts or branded formulations. This market is served by 3 tracked buyers.

Named Trastuzumab importers in Netherlands: MYLAN IRELAND LIMITED is the largest buyer, accounting for 43.1% ($12.6M) of this market's total imports.

• MYLAN IRELAND LIMITED — $12.6M (43.1% of Netherlands's total)

• BIOSIMILAR COLLABORATIONS IRELAND L — $8.8M (30.1% of Netherlands's total)

• MYLAN IRELAND LTD — $7.3M (24.9% of Netherlands's total)

Key Insight: Netherlands's per-shipment average of $133.6K (226% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

Netherlands is a key market for Trastuzumab imports from India.

Primary Market

Secondary Market

2Turkey

Turkey ranks as the second-largest destination for Trastuzumab imports from India, with a total trade value of $10.2M across 28 shipments — representing a 13.1% share of all Trastuzumab exports. The average shipment value of $362.6K is above the global average of $41.0K, indicating high-value procurement contracts or branded formulations. This market is served by 2 tracked buyers.

Named Trastuzumab importers in Turkey: ABDI IBRAHIM ILAC SANAYI VE TICARET is the largest buyer, accounting for 80.4% ($8.2M) of this market's total imports.

• ABDI IBRAHIM ILAC SANAYI VE TICARET — $8.2M (80.4% of Turkey's total)

• ABDI IBRAHIM ILAC SANAYI VE TICARET SANAYIMAH TUNC — $1.9M (18.8% of Turkey's total)

Key Insight: Turkey's per-shipment average of $362.6K (784% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

Turkey is a key market for Trastuzumab imports from India.

Primary Market

Secondary Market

3Ukraine

Ukraine ranks as the third-largest destination for Trastuzumab imports from India, with a total trade value of $4.3M across 10 shipments — representing a 5.6% share of all Trastuzumab exports. The average shipment value of $429.6K is above the global average of $41.0K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.

Named Trastuzumab importers in Ukraine: PII OST-WEST EXPRESS is the largest buyer, accounting for 100.0% ($4.3M) of this market's total imports.

• PII OST-WEST EXPRESS — $4.3M (100.0% of Ukraine's total)

Key Insight: Ukraine's per-shipment average of $429.6K (947% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

Ukraine is a key market for Trastuzumab imports from India.

Primary Market

Secondary Market

4Brazil

Brazil ranks as the fourth-largest destination for Trastuzumab imports from India, with a total trade value of $4.1M across 19 shipments — representing a 5.4% share of all Trastuzumab exports. The average shipment value of $217.7K is above the global average of $41.0K, indicating high-value procurement contracts or branded formulations. This market is served by 2 tracked buyers.

Named Trastuzumab importers in Brazil: BIOCON BIOLOGICS UK LIMITED is the largest buyer, accounting for 97.7% ($4.0M) of this market's total imports.

• BIOCON BIOLOGICS UK LIMITED — $4.0M (97.7% of Brazil's total)

• LIBBS FARMACEUTICA LTDA. — $1.7M (42.0% of Brazil's total)

Key Insight: Brazil's per-shipment average of $217.7K (430% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

Brazil is a key market for Trastuzumab imports from India.

Primary Market

Secondary Market

5United States

United States ranks as the fifth-largest destination for Trastuzumab imports from India, with a total trade value of $3.0M across 7 shipments — representing a 3.9% share of all Trastuzumab exports. The average shipment value of $428.1K is above the global average of $41.0K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.

Named Trastuzumab importers in United States: XXOSIXXLARXXNEWXX LIXXTED is the largest buyer, accounting for 104.4% ($3.1M) of this market's total imports.

• XXOSIXXLARXXNEWXX LIXXTED — $3.1M (104.4% of United States's total)

Key Insight: United States's per-shipment average of $428.1K (943% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

United States is a key market for Trastuzumab imports from India.

Primary Market

Secondary Market

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Network Construction: Supplier-to-buyer trade relationships constructed from verified shipment pairs in Indian Customs (DGFT) records for Trastuzumab.
2.Flow Mapping: 179 Indian manufacturers mapped to their international buyer networks using consignee name normalization.
3.Value Aggregation: Trade value per supplier-buyer link aggregated from 1,882 individual shipment records. Values are FOB in USD.
4.Geographic Clustering: Buyer networks clustered across 108 destination countries to identify geographic concentration patterns.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

1,882 Verified Shipments

179 manufacturers in network

Expert-Reviewed

By pharmaceutical trade specialists

Trastuzumab

Trastuzumab

Who Supplies Trastuzumab? Top Manufacturers & Their Global Buyers

🏭 Market Analysis: Top Suppliers & Customer Networks

Market Intelligence

Official References & Regulatory Resources

Who Supplies Trastuzumab? Top Manufacturers & Their Buyers

Supplier-Customer Network Analysis

Trastuzumab Supplier Network — Key Market Intelligence

Market Analysis: Top Suppliers & Their Customer Networks

1MYLAN LABORATORIES LIMITED

2BIOCON BIOLOGICS INDIA LIMITED

3ZYDUS LIFESCIENCES LIMITED

4RELIANCE LIFE SCIENCES PRIVATE LIMITED

5BIOCON BIOLOGICS LIMITED

6MEDWISE OVERSEAS PRIVATE LIMITED

From Indian Factories to Global Pharmacies — How Trastuzumab Flows

🌍 Market Analysis: Top Importing Countries & Importers

Where Does Trastuzumab Go? Top Importing Countries & Their Buyers

Geographic Market Flow Analysis

Market Analysis: Top Importing Countries & Their Importers

1Netherlands

2Turkey

3Ukraine

4Brazil

5United States

People Also Ask — Trastuzumab Supplier & Trade Network

Trastuzumab Trade Network — Key Takeaways

Network Overview

Supplier Network

Country Network

Network Insights

Related Analysis

Network Intelligence

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology